The Democratic Republic of Congo has declared an end to the national emergency linked to mpox, closing a chapter in one of Africa’s most consequential recent disease outbreaks and offering a rare note of public health relief for a country long burdened by overlapping crises.
The announcement, made by Health Minister Samuel Roger Kamba in Kinshasa in early April, means the outbreak no longer meets the threshold of a national public health emergency in Congo, where mpox spread on a scale that alarmed health officials across the region and prompted an international response. For the Congolese government and its partners, the decision is both a signal of progress and a test of whether gains made during an emergency can be sustained once the immediate crisis label is removed.
The outbreak was severe by any measure. According to reporting carried by The Associated Press and data cited from the Africa Centres for Disease Control and Prevention, Congo recorded more than 161,000 suspected mpox cases during the outbreak, around 37,000 laboratory-confirmed infections and more than 2,200 suspected deaths. Africa CDC said 2,286 deaths were classified as suspected, while only a much smaller share was laboratory confirmed, underscoring one of the central difficulties that shaped the response from the beginning: weak testing capacity in a country with vast distances, conflict-affected provinces and fragile health infrastructure.
That gap between suspected and confirmed cases is not a technical footnote. It helps explain why Congo’s mpox emergency became such a defining regional health challenge. Officials and aid groups were often forced to respond in an environment where disease surveillance lagged behind transmission, where laboratory confirmation could take time, and where outbreaks were complicated by insecurity and displacement in eastern parts of the country. In that context, simply declaring the emergency over does not erase the structural vulnerabilities that allowed the virus to gain ground.
Still, the end of the national emergency is a significant milestone. Congo’s health ministry said the country had reached a point where mpox no longer required management under emergency national status. AP reported that the decision followed months without new confirmed infections, suggesting that the response had moved from acute crisis mode toward a more stable phase of surveillance and control. The Congolese government also described the outcome as the result of sustained efforts by national authorities, frontline health workers and international partners.
The importance of the moment extends beyond Congo itself. The country was central to the broader mpox alarm that spread across Africa in 2024, when a surge in cases in Congo and neighboring countries triggered escalating concern at both the continental and global levels. Africa CDC declared the outbreak a Public Health Emergency of Continental Security in August 2024, and the World Health Organization followed on August 14, 2024 by designating the upsurge in Congo and its cross-border spread as a public health emergency of international concern.
Those declarations reflected fears not only about case numbers, but about the nature of transmission and the challenge of containing the outbreak in places where routine health systems were already overstretched. WHO said the outbreak in Congo posed a high risk, and later situation reports noted that the country continued to carry the heaviest mpox burden in Africa. For much of that period, Congo was not just another affected state. It was the center of gravity of the continental outbreak.
That is why the current announcement carries symbolic weight. In a region where public health emergencies can become prolonged and normalized, ending national emergency status signals that sustained disease control remains possible even in difficult operating conditions. It is also a reminder that epidemic response is often cumulative. The progress now being recognized did not come from one breakthrough, but from repeated work on surveillance, testing, clinical care, contact tracing, vaccine support and coordination between national and international actors.
At the same time, officials have been careful not to suggest that mpox has disappeared. The distinction matters. Ending emergency status is not the same thing as declaring the virus eradicated from Congo. Mpox remains endemic in parts of Central and West Africa, and WHO has repeatedly warned that improvements in transmission trends should not be mistaken for the disappearance of risk. The organization lifted its global mpox emergency designation in September 2025, but said the threat persisted and that surveillance and response capacity would still be needed. Africa CDC also lifted its continental emergency designation in January 2026, describing the move as a milestone while emphasizing continued health-security vigilance.
That cautious framing is especially important in Congo, where health emergencies do not unfold in isolation. The country’s response capacity is shaped by conflict, population movement, under-resourced clinics and the difficulty of reaching remote communities. Public health specialists have long argued that outbreaks in Congo cannot be understood only through case counts. They also reflect the long-term condition of the health system itself. When the system is thin, even a disease that is biologically understood can become operationally hard to contain.
Mpox has followed that pattern. The disease, caused by an orthopoxvirus, is known to spread through close contact with infected people or animals, and symptoms can include rash, fever and lesions, though severity varies. During the recent outbreak in Africa, the concern was heightened by sustained transmission, regional spillover and uncertainty about where surveillance was weakest. Congo’s struggle with laboratory confirmation highlighted the broader issue: public health leaders were often making decisions in real time without a fully visible map of the outbreak.
That reality makes the current milestone all the more notable. It suggests that the country’s response improved enough to interrupt the emergency phase, even if long-term management challenges remain. It also offers a public demonstration that investments in outbreak preparedness, diagnostics and field response can change outcomes. WHO and Africa CDC have both pointed in recent months to stronger coordination, better leadership and improved response systems as reasons why the broader continental emergency could be downgraded.
For Congo’s government, the announcement is also political as well as epidemiological. Declaring the end of the emergency allows officials to present the country not only as the epicenter of a dangerous outbreak, but as a case study in recovery and control. That message matters domestically, where public trust in health institutions can be fragile, and internationally, where donor attention often fluctuates as crises fade from headlines.
The challenge now is what comes next. Health emergencies often attract funding, personnel and political urgency that are harder to sustain once the emergency label is removed. Yet the period after an outbreak is often when the most important work begins: maintaining surveillance, rebuilding routine care, preserving laboratory capacity, and ensuring that communities remain engaged rather than fatigued by health messaging. If those systems weaken, gains can unravel quickly.
So Congo’s declaration should be read in two ways at once. It is undeniably an achievement. A national emergency that lasted about two years, caused more than 161,000 suspected cases and left more than 2,200 suspected deaths has been brought under enough control for authorities to formally stand down from crisis footing. In regional public health terms, that is a major milestone.
But it is also a warning against complacency. The outbreak exposed how quickly mpox could exploit weak surveillance and stressed health systems, and how difficult it can be to count, confirm and contain cases in real time. Congo has earned a moment of recognition. The larger test is whether the end of the emergency becomes the start of a stronger, more durable public health posture — one capable not only of reacting to the next outbreak, but of seeing it early enough to prevent another crisis of this scale.”””
